What is efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, Viraday)?

Efavirenz (Efavirenz, referred to as EFV), emtricitabine (Emtricitabine, referred to as FTC), tenofovir (Tenofovir disoproxil fumarate, referred to as TDF), merged into a compound antiretroviral drug, commonly used under the trade name "Viraday".

This drug is a highly active antiretroviral therapy commonly used to treat human immunodeficiency virus (HIV) infection. Specifically:

1.Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It blocks viral replication by inhibiting HIV reverse transcriptase, thereby reducing the amount of virus in the body.

2.Emtricitabine (FTC) is a nucleoside reverse transcriptase inhibitor (NRTI). It also inhibits HIV replication by interfering with the virus's reverse transcriptase.

3.Tenofovir (TDF) It is also a nucleoside reverse transcriptase inhibitor (NRTI). It inhibits viral replication and plays a key role in treatment.

These three drugs are often combined as highly active antiretroviral therapies and are widely used to treatHIV infection. They work together to effectively slow down the replication and spread of the virus, help control virus levels, improve the patient's immune system function, and delay the progression of HIV infection to AIDS. But please note that using this drug to treat HIVIt needs to be carried out under the guidance of a professional doctor, and regular monitoring is required during the treatment process.

Efavirenz/Emtricitabine/Tenofovir (EFV+FTC+TDF, Viraday) is not currently available in the country, so patients cannot purchase it domestically and need to purchase it through overseas purchasing channels. The cheaper ones abroad are mainly Indian generic drugs, which cost around 380 yuan.